Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease

Cell Transplantation

Volumn 5, Issue 2, 1996, Pages 327-337

  Kopyov, O V ^a   Jacques, D ^a   Lieberman, A ^a   Duma, C M ^a   Rogers, R L ^a  

^a GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Fetal transplantation; Parkinson's disease

Indexed keywords

ADULT; AGED; ARTICLE; CELL TRANSPLANTATION; CLINICAL ARTICLE; CLINICAL TRIAL; FETUS; FETUS CELL; HUMAN; HUMAN TISSUE; MESENCEPHALON; PARKINSON DISEASE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0029983423     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0963-6897(95)02035-7     Document Type: Article

References (31)

1. R.A.E. Bakay D.L. Barrow M.S. Fiandaca P.M. Iuvone A. Schiff D.C. Collins Biochemical and behavioral correction of MPTP Parkinson-like syndrome by fetal cell transplantation Ann. NY Acad. Sci. 495 1987 623 640
2. K.S. Bankiewicz R.J. Plunkett D.M. Jacobowitz The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism: Histochemical and behavioral studies J. Neurosurg. 72 1990 231 244
3. W. Birkmayer O. Hornykiewicz The effect of L-3,4 Dihydroxy-phenylalanine L(-dopa) in parkinsonian akinesia Wien. Klin. Wochenschr. 73 1961 787
4. A. Bjorklund U. Stenevi Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants Brain Res. 177 1979 555 560
5. A. Bjorklund U. Stenevi R.H. Schmidt S.B. Bunnett F.H. Gage Intracerebral grafting of neuronal cell suspensions Acta Physiol. Scand. 522 1983 1 75 (Suppl.)
6. P. Brundin A. Bjorklund Survival, growth and function of dopaminergic neurons grafted to the brain Prog. Brain Res. 71 1987 293 308
7. CAPIT Committee Core Assessment Program for Intracerebral Transplantations (CAPIT) Mov. Disord. 7 1992 2 13
8. A. Carlsson M. Lindqvist P. Riederer 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists Nature 180 1957 1200
9. C.G. Cortzias M.H. Van Woert L.M. Schiffer Aromatic amino acids and modification of parkinsonism N. Engl. J. Med. 276 1967 374 379
10. S.B. Dunnett T.D. Hernandez A. Summerfield G.H. Jones G. Aributhnott Graft-derived recovery from 6-OHDA lesion: Specificity of ventral mesencephalic graft tissues Exp. Brain Res. 71 1988 411 424
11. H. Ehringer O. Hornykiewicz Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems Klin. Wochenschr. 38 1960 1236 1239
12. A. Fine S.P. Hunt W.H. Oertel Transplantation of embryonic marmoset dopaminergic neurons to the corpus striatum of marmosets rendered parkinsonian by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine Prog. Brain Res. 78 1988 479 489
13. C.R. Freed R.E. Breeze N.L. Rosenberg Transplantation of human fetal dopamine cells for Parkinson's disease Arch. Neurol. 47 1990 505 512
14. C.R. Freed R.E. Breeze N.L. Rosenberg Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease N. Engl. J. Med. 327 1992 1549 1555
15. F.H. Gage Fetal implants put to the test Nature (News & Views) 361 1994 405 406
16. B.T.H. Henderson C.G. Clough R.C. Hughes E.R. Hitchcock B.G. Kenny Implantation of human fetal ventral mesencephalon to the caudate nucleus in advanced Parkinson's disease Arch. Neurol. 48 1991 822 827
17. O. Lindvall P. Brundin H. Widner Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease Science 247 1990 574 577
18. O. Lindvall Neural transplantation in Parkinson's disease B. Dunnett A. Bjorklund Functional neural transplantation 1994 Raven Press New York 103 138
19. O. Lindvall G. Sawle H. Widner Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease Ann. Neurol. 35 1994 172 180
20. J.J. Lopez-Lozano G. Bravo B. Brera Can an analogy be drawn between the clinical evolution of Parkinson's patients who undergo autoimplantation of medulla and those of fetal ventral mesencephalon transplant recipients? O. Lindvall A. Bjorklund H. Widner Intracerebral transplantation in movement disorders: Experimental basis and clinical experiences 1991 Elsevier Amsterdam 87 98
21. I. Madrazo R. Franco-Bourland F. Ostrosky-Solis Fetal homotransplants (ventral mesencephalon and adrenal tissue) to the striatum of Parkinsonian subjects Arch. Neurol. 47 1990 1281 1285
22. R. Mandel P. Brundin A. Bjorklund The importance of graft placement and task complexity for transplant-induced recovery of simple and complex sensori-motor deficits in dopamine denervated rats Eur. J. Neurosci. 2 1990 888 894
23. H. Molina R. Quinones L. Alvarez Transplantation of human fetal mesencephalic tissue in caudate nucleus as treatment for Parkinson's disease: The Cuban experience O. Lindvall A. Bjorklund H. Widner Intracerebral transplantation in movement disorders: Experimental basis and clinical experiences 1991 Elsevier Amsterdam 99 110
24. M.J. Perlow W.J. Freed B.J. Hoffer A. Seiger L. Olson R.J. Wyatt Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system Science 204 1979 643 647
25. D.D. Spencer R.J. Robbins F. Naftolin Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease N. Engl. J. Med. 327 1992 1541 1548
26. R.E. Strecker T. Sharp P. Brundin T. Zetterstrom U. Ungerstedt A. Bjorklund Autoregulation of dopamine release and metabolism by intrastriatal nigral grafts as revealed by intracerebral dialysis Neuroscience 22 1987 169 178
27. H. Takayama J. Ray H.K. Raymon A. Baird Basic fibroblast growth factor increases dopaminergic survival and function in a rat model of Parkinson's disease Nature Med. 1 1995 53 58
28. J.R. Taylor J.D. Elsworth R.H. Roth J.R. Sladek T.J. Collier D.E. Redmond Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: A comparison with other types of grafts as controls Exp. Brain Res. 85 1991 335 348
29. H. Widner J. Tetrud S. Rehncrona Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N. Engl. J. Med. 327 1992 1556 1563
30. D.M. Yurek J.R. Sladek Dopamine replacement: Parkinson's Disease Ann. Rev. Neurosci. 13 1990 415 440
31. T. Zetterstrom P. Brundin F.H. Gage In vivo measurement of spontaneous release and metabolism of dopamine from intrastriatal nigral grafts using intracerebral dialysis Brain Res. 362 1986 344 350